Md. Code Regs. 09.10.03.01-1

Current through Register Vol. 51, No. 24, December 2, 2024

Section 09.10.03.01-1 - Restricted Use of Medications and Other Substances

The use of the following medications and other substances is permitted if quantitated at not more than the specified thresholds:

A. Acepromazine quantitated at not more than 10 nanograms per milliliter of HEPS in urine;

B. Albuterol quantitated at not more than 1 nanogram per milliliter of urine;

C. Butorphanol quantitated at not more than 300 nanograms per milliliter of total butorphanol in urine, or 2 nanograms per milliliter of free butorphanol in blood plasma or serum;

D. Caffeine quantitated at not more than 100 nanograms per milliliter of blood plasma or serum;

E. Cetirizine quantitated at not more than 6 nanograms per milliliter of blood plasma or serum;

F. Cimetidine quantitated at not more than 400 nanograms per milliliter of blood plasma or serum;

G. Cobalt quantitated at not more than 25 nanograms per milliliter of blood plasma or serum;

H. Dantrolene qunatitated at not more than 100 picrograms per milliliter of 5-hydroxydantrolene in blood plasma or serum;

I. Detomidine quantitated at not more than 2 nanograms per milliliter of carboxydetomidine in urine, or 1 nanogram of detomidine per milliliter o/blood plasma or serum;

J. Dimethlysulfoxide (DMSO) quantitated at not more than 10 micrograms per milliliter of blood plasma or serum;

K. Flunixin quantitated at not more than 5 nanograms per milliliter of blood plasma or serum;

L. Furosemide (Lasix), as provided in Regulation .08 of this chapter;

M. Gamma aminobutyric acid quantitated at not more than 110 nanograms per milliliter of blood plasma or serum;

N. Glycopyrrolate quantitated at not more than 3 picograms per milliliter of blood plasma or serum;

O. Guaifenesin quantitated at not more than 12 nanograms per milliliter of blood plasma or serum;

P. Ketoprofen quantitated at not more than 2 nanograms per milliliter of blood plasma or serum;

Q. Lidocaine quantitated at not more than 20 picograms per milliliter of total 3-hydroxylidocaine in blood plasma or serum;

R. Mepivacaine quantitated at not more than 10 nanograms per milliliter of total hydroxymepivacaine in urine, or the limit of detection of mepivacaine in blood plasma or serum;

S. Methocarbamol quantitated at not more than 1 nanogram per milliliter of blood plasma or serum;

T. Methylprednisone quantitated at not more than 100 picograms per milliliter of blood plasma or serum;

U. Omeprazole quantitated at not more than 10 nanograms per milliliter of blood plasma or serum;

V. Phenylbutazone quantitated at not more than 0.3 micrograms per milliliter of the blood plasma or serum;

W. Procaine Penicillin quantitated at not more than 25 nanograms per milliliter of blood plasma or serum;

X. Ranitidine quantitated at not more than 40 nanograms per milliliter of blood plasma or serum;

Y. Xylazine quantitated at not more than 200 picigrams per milliliter of blood plasma or serum;

Z. Nandrolone quantitated at not more than 1 nanogram per milliliter of urine taken from a gelding, filly, or mare;

AA. Boldenone quantitated at not more than 15 nanograms per milliliter of urine taken from a colt or horse;

BB. Testosterone quantitated at not more than 20 nanograms per milliliter of urine taken from a gelding; and

CC. Testosterone quantitated at not more than 55 nanograms per milliliter of urine taken from a filly or mare.

Md. Code Regs. 09.10.03.01-1

Regulation .01B amended as an emergency provision effective October 27, 1995 (22:23 Md. R. 1794); emergency status expired April 1, 1996
Regulation .01B amended effective October 29, 2001 (28:21 Md. R. 1855); October 24, 2005 (32:21 Md. R. 1707)
Regulation .01B amended as an emergency provision effective January 1, 2009 (35:24 Md. R. 2068); amended permanently effective February 23, 2009 (36:4 Md. R. 353)
Regulation .01B amended effective October 15, 2012 (39:20 Md. R. 1306); January 1, 2014 (40:20 Md. R. 1651)
Regulation .01-1 adopted effective January 1, 2014 (40:20 Md. R. 1651)
Regulation .01-1 amended effective October 13, 2014 (41:20 Md. R. 1112)
Regulation .01-1E-1 adopted as an emergency provision effective August 1, 2015 (42:16 Md. R. 1052)
Regulation .01-1 amended effective 42:21 Md. R. 1300, eff.10/26/2015; amended effective 43:4 Md. R. 331, eff.2/29/2016; amended effective 43:21 Md. R. 1165, eff. 10/24/2016; amended effective 45:6 Md. R. 318, eff. 3/26/2018; amended effective 47:10 Md. R. 515, eff. 5/18/2020; amended effective 48:4 Md. R. 176, eff. 3/1/2021; amended effective 49:3 Md. R.138, eff. 2/7/2022